VFC
53
5
NDAQ
62
2
XYL
49
4
BWA
48
2
CINF
53
2
BF.B
33
2
WDC
47
4
PLD
56
8
GPC
40
3
WEC
53
-2
DNB
82
4
APD
59
2
CMA
61
5
MHK
49
4
CSX
60
3
BBY
46
10
SLB
55
2
SNA
68
-2
A
43
2
LH
43
-2
VFC
53
5
NDAQ
62
2
XYL
49
4
BWA
48
2
CINF
53
2
BF.B
33
2
WDC
47
4
PLD
56
8
GPC
40
3
WEC
53
-2
DNB
82
4
APD
59
2
CMA
61
5
MHK
49
4
CSX
60
3
BBY
46
10
SLB
55
2
SNA
68
-2
A
43
2
LH
43
-2
Financhill
Back

Takeda Pharmaceutical 10K Form

Sell
20

TKPHF
Takeda Pharmaceutical

Last Price:
25.26
Seasonality Move:
5.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TKPHF News And Ratings

See the #1 stock for the next 7 days that we like better than TKPHF

TKPHF Financial Statistics

Sales & Book Value

Annual Sales: $29.55B
Cash Flow: $1.28B
Price / Cash Flow: 11.69
Annual Sales: $30.57
Price / Book: 0.83

Profitability

EPS (TTM): 1.20880
Net Income (TTM): $1.93B
Gross Margin: $19.66B
Return on Equity: 4.01%
Return on Assets: 1.91%

Takeda Pharmaceutical Earnings Forecast

Key Takeda Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 25 years for TKPHF is 66.54%.
  • The Selling, General & Administrative Expenses for TKPHF have been equal to 24.72% of Gross Profit Margin.
  • The Research & Development expenses have been 17.12% of Revenue.
  • The Interest Expense is 82.97% of Operating Income.
  • The Net Earning history of TKPHF is 3.38% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 15 years.

Takeda Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TKPHF
Website: takeda.com

Debt

Debt-to-Equity Ratio: 0.73
Current Ratio: 1.28
Quick Ratio: 0.68

Price-to-Earnings

Trailing P/E Ratio: 39.98
Forward P/E Ratio: 0

TKPHF Technical Analysis vs Fundamental Analysis

Sell
20
Takeda Pharmaceutical (TKPHF) is a Sell

Is Takeda Pharmaceutical a Buy or a Sell?